Colin Murdoch, president of Isomorphic Labs and Ron Alfa, CEO and co-founder of Noetik, join Washington Post Live to discuss the future of diagnostics, precision medicine, the Trump administration's recent cuts to cancer research and the evolution of cancer care.

Conversation recorded on Wednesday, September 17, 2025.
Program sponsored by Pfizer